Loading...

Viemed Healthcare

TSX:VMD
Snowflake Description

Solid track record with high growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
VMD
TSX
CA$370M
Market Cap
  1. Home
  2. CA
  3. Healthcare
Company description

Viemed Healthcare, Inc., through its subsidiaries, provides in-home health care solutions in the United States. The last earnings update was 49 days ago. More info.


Add to Portfolio Compare Print
  • Viemed Healthcare has significant price volatility in the past 3 months.
VMD Share Price and Events
7 Day Returns
-2.2%
TSX:VMD
-0.5%
CA Healthcare
1.2%
CA Market
1 Year Returns
131.9%
TSX:VMD
18.2%
CA Healthcare
-2.6%
CA Market
VMD Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Viemed Healthcare (VMD) -2.2% 3.7% 47.1% 131.9% - -
CA Healthcare -0.5% -2.3% -1.1% 18.2% -4.2% 28.1%
CA Market 1.2% 1.3% 1% -2.6% 12.8% 2.2%
1 Year Return vs Industry and Market
  • VMD outperformed the Healthcare industry which returned 18.2% over the past year.
  • VMD outperformed the Market in Canada which returned -2.6% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is Viemed Healthcare undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Viemed Healthcare to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Viemed Healthcare.

TSX:VMD Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 3 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 6.7%
Perpetual Growth Rate 10-Year CA Government Bond Rate 1.9%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for TSX:VMD
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CA Govt Bond Rate 1.9%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.64
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.641 (1 + (1- 21%) (2.56%))
0.768
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.95% + (0.8 * 5.96%)
6.72%

Discounted Cash Flow Calculation for TSX:VMD using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Viemed Healthcare is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

TSX:VMD DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 6.72%)
2019 24.08 Est @ 39.94% 22.57
2020 30.96 Est @ 28.55% 27.19
2021 37.33 Est @ 20.57% 30.71
2022 42.92 Est @ 14.98% 33.09
2023 47.67 Est @ 11.07% 34.44
2024 51.64 Est @ 8.33% 34.97
2025 54.96 Est @ 6.42% 34.87
2026 57.75 Est @ 5.08% 34.33
2027 60.13 Est @ 4.14% 33.50
2028 62.23 Est @ 3.48% 32.49
Present value of next 10 years cash flows $318.17
TSX:VMD DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $62.23 × (1 + 1.95%) ÷ (6.72% – 1.95%)
$1,330.52
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $1,330.52 ÷ (1 + 6.72%)10
$694.65
TSX:VMD Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $318.17 + $694.65
$1,012.82
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $1,012.82 / 37.68
$26.88
TSX:VMD Discount to Share Price
Calculation Result
Exchange Rate USD/CAD
(Reporting currency to currency of TSX:VMD)
1.321
Value per Share
(CAD)
= Value per Share in USD x Exchange Rate (USD/CAD)
= $26.88 x 1.321
CA$35.52
Value per share (CAD) From above. CA$35.52
Current discount Discount to share price of CA$9.81
= -1 x (CA$9.81 - CA$35.52) / CA$35.52
72.4%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Viemed Healthcare is available for.
Intrinsic value
>50%
Share price is CA$9.81 vs Future cash flow value of CA$35.52
Current Discount Checks
For Viemed Healthcare to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Viemed Healthcare's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Viemed Healthcare's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Viemed Healthcare's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Viemed Healthcare's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
TSX:VMD PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $0.26
TSX:VMD Share Price ** TSX (2019-06-21) in CAD CA$9.81
TSX:VMD Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.757 $7.42
Canada Healthcare Industry PE Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 47.26x
Canada Market PE Ratio Median Figure of 542 Publicly-Listed Companies 15.1x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Viemed Healthcare.

TSX:VMD PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSX:VMD Share Price ÷ EPS (both in USD)

= 7.42 ÷ 0.26

28.14x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Viemed Healthcare is good value based on earnings compared to the CA Healthcare industry average.
  • Viemed Healthcare is overvalued based on earnings compared to the Canada market.
Price based on expected Growth
Does Viemed Healthcare's expected growth come at a high price?
Raw Data
TSX:VMD PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 28.14x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts
28.4%per year
North America Healthcare Industry PEG Ratio Median Figure of 47 Publicly-Listed Healthcare Companies 1.67x
Canada Market PEG Ratio Median Figure of 248 Publicly-Listed Companies 1.18x

*Line of best fit is calculated by linear regression .

TSX:VMD PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 28.14x ÷ 28.4%

0.99x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Viemed Healthcare is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Viemed Healthcare's assets?
Raw Data
TSX:VMD PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $0.97
TSX:VMD Share Price * TSX (2019-06-21) in CAD CA$9.81
TSX:VMD Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.757 $7.42
Canada Healthcare Industry PB Ratio Median Figure of 23 Publicly-Listed Healthcare Companies 2.35x
Canada Market PB Ratio Median Figure of 2,425 Publicly-Listed Companies 1.43x
TSX:VMD PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSX:VMD Share Price ÷ Book Value per Share (both in USD)

= 7.42 ÷ 0.97

7.65x

* Primary Listing of Viemed Healthcare.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Viemed Healthcare is overvalued based on assets compared to the CA Healthcare industry average.
X
Value checks
We assess Viemed Healthcare's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Viemed Healthcare has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Viemed Healthcare expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
28.4%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Viemed Healthcare expected to grow at an attractive rate?
  • Viemed Healthcare's earnings growth is expected to exceed the low risk savings rate of 1.9%.
Growth vs Market Checks
  • Viemed Healthcare's earnings growth is expected to exceed the Canada market average.
  • Viemed Healthcare's revenue growth is expected to exceed the Canada market average.
Annual Growth Rates Comparison
Raw Data
TSX:VMD Future Growth Rates Data Sources
Data Point Source Value (per year)
TSX:VMD Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts 28.4%
TSX:VMD Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 3 Analysts 23.8%
Canada Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 53.7%
Canada Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 16%
Canada Market Earnings Growth Rate Market Cap Weighted Average 14.9%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
TSX:VMD Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
TSX:VMD Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 108 20 15 3
2019-12-31 86 16 10 3
TSX:VMD Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 72 22 10
2018-12-31 65 22 10
2018-09-30 60 15 7
2018-06-30 56 13 9
2018-03-31 51 9 8
2017-12-31 47 12 8
2017-09-30 43 14 11
2016-12-31 31 6 1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Viemed Healthcare's earnings are expected to grow significantly at over 20% yearly.
  • Viemed Healthcare's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
TSX:VMD Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below

All data from Viemed Healthcare Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:VMD Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31 0.47 0.49 0.44 2.00
2019-12-31 0.32 0.35 0.29 2.00
TSX:VMD Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 0.26
2018-12-31 0.27
2018-09-30 0.19
2018-06-30 0.23
2018-03-31 0.21
2017-12-31 0.22
2017-09-30 0.18
2016-12-31 0.03

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Viemed Healthcare will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Viemed Healthcare's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Viemed Healthcare has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Viemed Healthcare performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Viemed Healthcare's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Viemed Healthcare's year on year earnings growth rate has been positive over the past 5 years.
  • Viemed Healthcare's 1-year earnings growth exceeds its 5-year average (23.2% vs 2.5%)
  • Viemed Healthcare's earnings growth has exceeded the CA Healthcare industry average in the past year (23.2% vs -73.3%).
Earnings and Revenue History
Viemed Healthcare's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Viemed Healthcare Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:VMD Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 71.60 9.99 41.66 0.23
2018-12-31 65.27 10.18 37.14
2018-09-30 60.33 7.11 36.32
2018-06-30 55.62 8.70 31.35
2018-03-31 51.01 8.11 28.64
2017-12-31 46.93 8.18 25.39
2017-09-30 42.57 11.19 16.50
2016-12-31 31.36 1.23 18.14
2015-12-31 37.57 9.69 18.18
2014-12-31 23.29 9.45 9.56

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Viemed Healthcare has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
  • Viemed Healthcare used its assets more efficiently than the CA Healthcare industry average last year based on Return on Assets.
  • Viemed Healthcare's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Viemed Healthcare's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Viemed Healthcare has a total score of 5/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Viemed Healthcare's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Viemed Healthcare's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Viemed Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Viemed Healthcare's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Viemed Healthcare's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 3.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Viemed Healthcare Company Filings, last reported 2 months ago.

TSX:VMD Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 36.55 0.00 7.41
2018-12-31 35.03 0.00 10.41
2018-09-30 32.78 0.00 10.17
2018-06-30 29.68 0.00 8.55
2018-03-31 26.65 0.00 4.63
2017-12-31 23.74 0.00 5.10
2017-09-30 21.08 0.00 7.27
2016-12-31 12.88 0.46 4.34
2015-12-31 11.65 1.90 3.15
2014-12-31 8.43 0.03 1.64
  • Viemed Healthcare's level of debt (19.6%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Viemed Healthcare's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (308.1%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 68.3x coverage).
X
Financial health checks
We assess Viemed Healthcare's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Viemed Healthcare has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Viemed Healthcare's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Viemed Healthcare dividends.
If you bought CA$2,000 of Viemed Healthcare shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Viemed Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Viemed Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
TSX:VMD Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
North America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 25 Stocks 1.6%
Canada Market Average Dividend Yield Market Cap Weighted Average of 335 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2.1%
Canada Top 25% Dividend Yield 75th Percentile 5.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

TSX:VMD Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Viemed Healthcare has not reported any payouts.
  • Unable to verify if Viemed Healthcare's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Viemed Healthcare's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Viemed Healthcare has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Viemed Healthcare's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Viemed Healthcare afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Viemed Healthcare has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Viemed Healthcare's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Casey Hoyt
COMPENSATION $1,828,844
AGE 41
CEO Bio

Mr. Casey Hoyt has been Director of Viemed Healthcare, Inc. since December 14, 2016 and serves as Chief Executive Officer. Mr. Hoyt served as Chief Executive Officer of Patient Home Monitoring Corp. from June 2015 to December 2017. He co-founded Sleep Management LLC in 2006 and serves as its Co-Chief Executive Officer. He views his most important roles as recruiting, motivating and managing the quality employees that Sleep Management has become respected for throughout the healthcare industry. Prior to starting Sleep Management, Mr. Hoyt held a successful track record of running successful businesses Nimlok Louisiana, offering a comprehensive line of tradeshow display and marketing services. He is known for his fun-loving and kind personality. He served as a Director of Patient Home Monitoring Corp. from February 10, 2016 to December 2017.

CEO Compensation
  • Casey's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Casey's remuneration is higher than average for companies of similar size in Canada.
Management Team Tenure

Average tenure and age of the Viemed Healthcare management team in years:

1.5
Average Tenure
43.5
Average Age
  • The average tenure for the Viemed Healthcare management team is less than 2 years, this suggests a new team.
Management Team

Casey Hoyt

TITLE
CEO & Director
COMPENSATION
$2M
AGE
41

Michael Moore

TITLE
President
COMPENSATION
$2M
TENURE
1.5 yrs

Trae Fitzgerald

TITLE
Chief Financial Officer
COMPENSATION
$593K
TENURE
1.5 yrs

W. Zehnder

TITLE
COO & Director
COMPENSATION
$2M
AGE
43

William Frazier

TITLE
Chief Medical Officer & Director
COMPENSATION
$421K
AGE
60

Kavish Shah

TITLE
Chief Information Officer

Brett Stoute

TITLE
Chief Compliance Officer

Robbie Grossman

TITLE
Corporate Secretary
AGE
44
TENURE
1.5 yrs
Board of Directors Tenure

Average tenure and age of the Viemed Healthcare board of directors in years:

1.5
Average Tenure
51
Average Age
  • The average tenure for the Viemed Healthcare board of directors is less than 3 years, this suggests a new board.
Board of Directors

Randy Dobbs

TITLE
Chairman
COMPENSATION
$213K
AGE
67
TENURE
1.5 yrs

Casey Hoyt

TITLE
CEO & Director
COMPENSATION
$2M
AGE
41
TENURE
2.5 yrs

W. Zehnder

TITLE
COO & Director
COMPENSATION
$2M
AGE
43
TENURE
1.5 yrs

William Frazier

TITLE
Chief Medical Officer & Director
COMPENSATION
$421K
AGE
60
TENURE
1.5 yrs

Nitin Kaushal

TITLE
Director
COMPENSATION
$213K
AGE
52
TENURE
1.5 yrs

Tim Smokoff

TITLE
Director
COMPENSATION
$213K
TENURE
1.5 yrs

Bruce Greenstein

TITLE
Independent Director
COMPENSATION
$112K
AGE
50
TENURE
0.9 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
09. Jan 19 Sell W. Zehnder Individual 04. Jan 19 04. Jan 19 -44,601 CA$5.47 CA$-243,967
09. Jan 19 Sell Trae Fitzgerald Individual 04. Jan 19 04. Jan 19 -12,475 CA$5.47 CA$-68,238
09. Jan 19 Sell Michael Moore Individual 04. Jan 19 04. Jan 19 -31,808 CA$5.47 CA$-173,990
09. Jan 19 Sell Casey Hoyt Individual 04. Jan 19 04. Jan 19 -32,625 CA$5.47 CA$-178,459
20. Nov 18 Buy Michael Moore Individual 19. Nov 18 19. Nov 18 11,000 CA$6.01 CA$66,155
20. Nov 18 Buy Casey Hoyt Individual 20. Nov 18 20. Nov 18 10,000 CA$4.54 CA$45,434
X
Management checks
We assess Viemed Healthcare's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Viemed Healthcare has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

How Viemed Healthcare, Inc. (TSE:VMD) Could Add Value To Your Portfolio

By this I mean, I look at stocks holistically, from their financial health to their future outlook. … TSX:VMD Past and Future Earnings, June 5th 2019 VMD's strong financial health means that all of its upcoming liability payments are able to be met by its current cash and short-term investment holdings. … This indicates that VMD has sufficient cash flows and proper cash management in place, which is a key determinant of the company’s health.

Simply Wall St -

Viemed Healthcare, Inc. (TSE:VMD) Earns Among The Best Returns In Its Industry

Analysts use this formula to calculate return on capital employed: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) Or for Viemed Healthcare: 0.28 = US$11m ÷ (US$59m - US$19m) (Based on the trailing twelve months to March 2019.) So, Viemed Healthcare has an ROCE of 28%. … What Are Current Liabilities, And How Do They Affect Viemed Healthcare's ROCE? … Due to the way ROCE is calculated, a high level of current liabilities makes a company look as though it has less capital employed, and thus can (sometimes unfairly) boost the ROCE.

Simply Wall St -

Read This Before You Buy Viemed Healthcare, Inc. (TSE:VMD) Because Of Its P/E Ratio

Viemed Healthcare has a P/E ratio of 21.99, based on the last twelve months. … Price to Earnings Ratio = Price per Share (in the reporting currency) ÷ Earnings per Share (EPS) … P/E of 21.99 = $5.91 (Note: this is the share price in the reporting currency, namely, USD ) ÷ $0.27

Simply Wall St -

Is Viemed Healthcare's (TSE:VMD) Share Price Gain Of 137% Well Earned?

On the other hand, if you find a high quality business to buy (at the right price) you can more than double your money! … (TSE:VMD) share price has soared 137% return in just a single year. … On top of that, the share price is up 29% in about a quarter.

Simply Wall St -

A Closer Look At Viemed Healthcare, Inc.'s (TSE:VMD) Impressive ROE

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. … Another way to think of that is that for every CA$1 worth of equity in the company, it was able to earn CA$0.29. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

What Percentage Of Viemed Healthcare, Inc. (TSE:VMD) Shares Do Insiders Own?

A look at the shareholders of Viemed Healthcare, Inc. … As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.'. … Let's take a closer look to see what the different types of shareholder can tell us about VMD

Simply Wall St -

Does Viemed Healthcare, Inc.'s (TSE:VMD) P/E Ratio Signal A Buying Opportunity?

This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). … Viemed Healthcare has a price to earnings ratio of 21.21, based on the last twelve months. … Price to Earnings Ratio = Price per Share (in the reporting currency) ÷ Earnings per Share (EPS)

Simply Wall St -

Are Insiders Buying Viemed Healthcare, Inc. (TSE:VMD) Stock?

We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. … Viemed Healthcare Insider Transactions Over The Last Year. … In the last twelve months there was more buying than selling by Viemed Healthcare insiders

Simply Wall St -

Is Viemed Healthcare Inc's (TSE:VMD) Balance Sheet A Threat To Its Future?

Viemed Healthcare Inc (TSE:VMD) is a small-cap stock with a market capitalization of CA$204m. … While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Healthcare companies,.

Simply Wall St -

Viemed Healthcare Inc (TSE:VMD) Has A ROE Of 22%

By way of learning-by-doing, we'll look at ROE to gain a better understanding Viemed Healthcare Inc (TSE:VMD). … That means that for every CA$1 worth of shareholders' equity, it generated CA$0.22 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Company Info

Description

Viemed Healthcare, Inc., through its subsidiaries, provides in-home health care solutions in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators, positive airway pressure machines, and oxygen units, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing to determine the existence of sleep apnea at home. In addition, the company leases equipment, including non-invasive ventilators, BiPaP and CPaP devices, percussion vests, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy, education, and counseling to patients in their homes using technology. The company is headquartered in Lafayette, Louisiana.

Details
Name: Viemed Healthcare, Inc.
VMD
Exchange: TSX
Founded:
CA$369,649,609
37,680,898
Website: http://www.viemed.com
Address: Viemed Healthcare, Inc.
202 North Luke Street,
Lafayette,
Louisiana, 70506,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSX VMD Common Shares The Toronto Stock Exchange CA CAD 22. Dec 2017
OTCPK VIEM.F Common Shares Pink Sheets LLC US USD 22. Dec 2017
Number of employees
Current staff
Staff numbers
293
Viemed Healthcare employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/24 01:11
End of day share price update: 2019/06/21 00:00
Last estimates confirmation: 2019/05/24
Last earnings filing: 2019/05/06
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.